RAPAFLO is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Silodosin.
Product ID | 0023-6142_6cba0207-6e74-431e-9298-710b5fc592d4 |
NDC | 0023-6142 |
Product Type | Human Prescription Drug |
Proprietary Name | RAPAFLO |
Generic Name | Silodosin |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2009-03-23 |
Marketing Category | NDA / NDA |
Application Number | NDA022206 |
Labeler Name | Allergan, Inc. |
Substance Name | SILODOSIN |
Active Ingredient Strength | 8 mg/1 |
Pharm Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2009-03-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022206 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-03-23 |
Marketing Category | NDA |
Application Number | NDA022206 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-03-23 |
Ingredient | Strength |
---|---|
SILODOSIN | 8 mg/1 |
SPL SET ID: | da0314f6-b1d6-44ee-8b1e-f763dbb8613f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0023-6142 | RAPAFLO | silodosin |
0023-6147 | RAPAFLO | silodosin |
52544-151 | RAPAFLO | silodosin |
52544-152 | RAPAFLO | silodosin |
0781-2623 | Silodosin | Silodosin |
0781-2624 | Silodosin | Silodosin |
27241-144 | Silodosin | Silodosin |
27241-145 | Silodosin | Silodosin |
31722-635 | Silodosin | Silodosin |
31722-636 | Silodosin | Silodosin |
33342-384 | Silodosin | Silodosin |
33342-385 | Silodosin | Silodosin |
42291-777 | Silodosin | Silodosin |
42291-778 | Silodosin | Silodosin |
46708-405 | Silodosin | Silodosin |
46708-406 | Silodosin | Silodosin |
59651-095 | SILODOSIN | SILODOSIN |
59651-096 | SILODOSIN | SILODOSIN |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RAPAFLO 78634385 3644962 Live/Registered |
Watson Pharmaceuticals, Inc. 2005-05-20 |
RAPAFLO 77605175 3681361 Live/Registered |
Watson Pharmaceuticals, Inc. 2008-10-31 |